The ophthalmology field has reached a pivotal moment with the introduction of an unprecedented therapeutic solution for one of retinal medicine's most challenging disorders. After years of limited treatment options, patients diagnosed with macular telangiectasia type 2 now have access to a scientifically proven intervention that directly addresses their condition's...